Telomere length as a biomarker in Paediatric Cancers

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Telomeres are the ends of chromosomes, and their length is important to maintain cell viability. We intend to set up a reliable test to measure telomere length and also use this measurement in childhood cancer patients to assess whether patients with shorter telomeres are more susceptible to the adverse effects of chemotherapy and radiotherapy.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2016

Funding Scheme: Postgraduate Scholarships

Funding Amount: $121,025.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Clinical Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer | cancer chemotherapy | cancer follow-up | chemotherapy treatment effects | paediatric | telomeres